Titre : Oxidoreductases, (N-demethylating)

Oxidoreductases, (N-demethylating) : Questions médicales fréquentes

Termes MeSH sélectionnés :

Single-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Oxidoreductases, (N-demethylating) : Questions médicales les plus fréquentes", "headline": "Oxidoreductases, (N-demethylating) : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Oxidoreductases, (N-demethylating) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-26", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Oxidoreductases, (N-demethylating)" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxidoreductases acting on CH-NH group donors", "url": "https://questionsmedicales.fr/mesh/D000587", "about": { "@type": "MedicalCondition", "name": "Oxidoreductases acting on CH-NH group donors", "code": { "@type": "MedicalCode", "code": "D000587", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aminopyrine N-demethylase", "alternateName": "Aminopyrine N-Demethylase", "url": "https://questionsmedicales.fr/mesh/D000633", "about": { "@type": "MedicalCondition", "name": "Aminopyrine N-demethylase", "code": { "@type": "MedicalCode", "code": "D000633", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.276" } } }, { "@type": "MedicalWebPage", "name": "Dihydropteridine reductase", "alternateName": "Dihydropteridine Reductase", "url": "https://questionsmedicales.fr/mesh/D004093", "about": { "@type": "MedicalCondition", "name": "Dihydropteridine reductase", "code": { "@type": "MedicalCode", "code": "D004093", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.361" } } }, { "@type": "MedicalWebPage", "name": "Dimethylglycine dehydrogenase", "alternateName": "Dimethylglycine Dehydrogenase", "url": "https://questionsmedicales.fr/mesh/D050893", "about": { "@type": "MedicalCondition", "name": "Dimethylglycine dehydrogenase", "code": { "@type": "MedicalCode", "code": "D050893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.369" } } }, { "@type": "MedicalWebPage", "name": "Ethylmorphine-N-demethylase", "alternateName": "Ethylmorphine-N-Demethylase", "url": "https://questionsmedicales.fr/mesh/D005037", "about": { "@type": "MedicalCondition", "name": "Ethylmorphine-N-demethylase", "code": { "@type": "MedicalCode", "code": "D005037", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.400" } } }, { "@type": "MedicalWebPage", "name": "Histone Demethylases", "alternateName": "Histone Demethylases", "url": "https://questionsmedicales.fr/mesh/D056466", "about": { "@type": "MedicalCondition", "name": "Histone Demethylases", "code": { "@type": "MedicalCode", "code": "D056466", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.475" } } }, { "@type": "MedicalWebPage", "name": "Sarcosine dehydrogenase", "alternateName": "Sarcosine Dehydrogenase", "url": "https://questionsmedicales.fr/mesh/D050892", "about": { "@type": "MedicalCondition", "name": "Sarcosine dehydrogenase", "code": { "@type": "MedicalCode", "code": "D050892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.662.582.550" } } } ], "about": { "@type": "MedicalCondition", "name": "Oxidoreductases, (N-demethylating)", "alternateName": "Oxidoreductases, N-Demethylating", "code": { "@type": "MedicalCode", "code": "D010089", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christopher J Schofield", "url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield", "affiliation": { "@type": "Organization", "name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK." } }, { "@type": "Person", "name": "Rajeev Ramanan", "url": "https://questionsmedicales.fr/author/Rajeev%20Ramanan", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA." } }, { "@type": "Person", "name": "Sodiq O Waheed", "url": "https://questionsmedicales.fr/author/Sodiq%20O%20Waheed", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA." } }, { "@type": "Person", "name": "Christo Z Christov", "url": "https://questionsmedicales.fr/author/Christo%20Z%20Christov", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA." } }, { "@type": "Person", "name": "Samuel E Ross", "url": "https://questionsmedicales.fr/author/Samuel%20E%20Ross", "affiliation": { "@type": "Organization", "name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial.", "datePublished": "2023-12-06", "url": "https://questionsmedicales.fr/article/38056935", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-069369" } }, { "@type": "ScholarlyArticle", "name": "Randomized, Placebo-Controlled, Single-Blind Study of Lutein Supplementation on Carotenoid Status and Cognition in Persons with Multiple Sclerosis.", "datePublished": "2023-06-25", "url": "https://questionsmedicales.fr/article/37364683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tjnut.2023.06.027" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Acetylcysteine and Selenium in Aneurysmal Subarachnoid Hemorrhage Patients: A Prospective, Multicenter, Single Blind Randomized Controlled Trial.", "datePublished": "2023-05-29", "url": "https://questionsmedicales.fr/article/37270916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2023.38.e161" } }, { "@type": "ScholarlyArticle", "name": "Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36918838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-023-04664-5" } }, { "@type": "ScholarlyArticle", "name": "Immediate Effects of Mulligan Mobilization on Elbow Proprioception in Healthy Individuals: A Randomized Placebo-Controlled Single-Blind Study.", "datePublished": "2023-07-07", "url": "https://questionsmedicales.fr/article/37422752", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jmpt.2023.05.001" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "Oxidoreductases acting on CH-NH group donors", "item": "https://questionsmedicales.fr/mesh/D000587" }, { "@type": "ListItem", "position": 6, "name": "Oxidoreductases, (N-demethylating)", "item": "https://questionsmedicales.fr/mesh/D010089" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Oxidoreductases, (N-demethylating) - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Oxidoreductases, (N-demethylating)", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Oxidoreductases, (N-demethylating)", "description": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?\nQuels tests sont utilisés pour évaluer l'activité enzymatique ?\nQuels symptômes peuvent indiquer un dysfonctionnement enzymatique ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Oxidoreductases, (N-demethylating)", "description": "Quels symptômes sont associés à une altération de la déméthylation ?\nLes troubles neurologiques peuvent-ils être liés à ces enzymes ?\nComment les effets secondaires des médicaments sont-ils liés ?\nLes symptômes varient-ils selon les individus ?\nY a-t-il des symptômes spécifiques aux enfants ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Oxidoreductases, (N-demethylating)", "description": "Comment prévenir les complications liées à la déméthylation ?\nY a-t-il des tests préventifs recommandés ?\nL'éducation des patients est-elle importante ?\nLes habitudes de vie peuvent-elles influencer la fonction enzymatique ?\nDes vaccinations peuvent-elles aider à prévenir des complications ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Oxidoreductases, (N-demethylating)", "description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nPeut-on utiliser des suppléments pour améliorer la fonction enzymatique ?\nLes modifications alimentaires peuvent-elles aider ?\nDes thérapies géniques sont-elles envisageables ?\nLes médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Oxidoreductases, (N-demethylating)", "description": "Quelles complications peuvent survenir en cas de dysfonctionnement ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nY a-t-il des complications spécifiques aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Oxidoreductases, (N-demethylating)", "description": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge joue-t-il un rôle dans le risque de dysfonctionnement ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?\nLe mode de vie influence-t-il le risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Single-Blind+Method&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité enzymatique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolisme des médicaments et des dosages enzymatiques sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un dysfonctionnement enzymatique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des réactions médicamenteuses inattendues peuvent survenir." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains biomarqueurs peuvent indiquer une activité enzymatique altérée." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent mesurer les niveaux de métabolites spécifiques." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une altération de la déméthylation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées, des vomissements et des réactions cutanées peuvent se manifester." } }, { "@type": "Question", "name": "Les troubles neurologiques peuvent-ils être liés à ces enzymes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent survenir en raison d'une accumulation de toxines." } }, { "@type": "Question", "name": "Comment les effets secondaires des médicaments sont-ils liés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une déméthylation inefficace peut entraîner des effets secondaires imprévus." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les individus ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la génétique et de l'environnement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus aigus, comme des troubles de l'attention." } }, { "@type": "Question", "name": "Comment prévenir les complications liées à la déméthylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les médicaments connus pour interférer avec la déméthylation peut aider." } }, { "@type": "Question", "name": "Y a-t-il des tests préventifs recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être recommandés pour les personnes à risque." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les médicaments et leurs effets est crucial." } }, { "@type": "Question", "name": "Les habitudes de vie peuvent-elles influencer la fonction enzymatique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent améliorer la fonction enzymatique." } }, { "@type": "Question", "name": "Des vaccinations peuvent-elles aider à prévenir des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui compliquent les traitements." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements symptomatiques et des ajustements médicamenteux peuvent être nécessaires." } }, { "@type": "Question", "name": "Peut-on utiliser des suppléments pour améliorer la fonction enzymatique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments comme les antioxydants peuvent aider à soutenir la fonction enzymatique." } }, { "@type": "Question", "name": "Les modifications alimentaires peuvent-elles aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir le métabolisme et la fonction enzymatique." } }, { "@type": "Question", "name": "Des thérapies géniques sont-elles envisageables ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est une option potentielle pour corriger des déficiences enzymatiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ajuster les doses ou changer de médicament peut réduire les effets indésirables." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de dysfonctionnement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions médicamenteuses graves peuvent se produire." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en provoquant des symptômes chroniques." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance régulière et des ajustements de traitement peuvent prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des complications spécifiques aux traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements peuvent entraîner des complications spécifiques, comme des allergies." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque de dysfonctionnement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque peut augmenter avec l'âge en raison de la diminution de la fonction enzymatique." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles enzymatiques augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à des toxines peut-elle augmenter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut affecter la fonction enzymatique." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque de complications ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque de complications liées à la déméthylation." } } ] } ] }

Sources (10000 au total)

Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial.

Dry eye (DE) is a multifactorial ocular surface disease causing considerable medical, social and financial implications. Currently, there is no recognised long-term, effective treatment to alleviate D... This is a multicentre, randomised, sham-controlled trial. A total of 168 patients with DE will be enrolled and randomly assigned to EA or sham EA groups to receive 4-week consecutive treatments and fo... The trial protocol and informed consent were approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditiona... NCT05552820....

Randomized, Placebo-Controlled, Single-Blind Study of Lutein Supplementation on Carotenoid Status and Cognition in Persons with Multiple Sclerosis.

Multiple sclerosis (MS) is traditionally managed using disease-modifying pharmaceutical therapies as a first line approach for treatment, yet there is increasing interest in lifestyle factors, particu... This study aimed to investigate the efficacy of 4-mo lutein supplementation on carotenoid status and cognition in persons with relapse-remitting MS (RRMS).... A randomized controlled, single-blind research design was used among adults with RRMS (N = 21). Participants were randomized into placebo (n = 9) or treatment (20-mg/d lutein, n = 12) groups with outc... There was a significant group by time interaction for MPOD (F = 6.74, P = 0.02), skin carotenoids (F = 17.30, P < 0.01), and serum lutein (F = 24.10, P < 0.01), whereby the treatment group improved in... Lutein supplementation increases carotenoid status among persons with RRMS. There is no significant effect on cognitive function but change in macular carotenoids is selectively associated with improv...

Efficacy of Acetylcysteine and Selenium in Aneurysmal Subarachnoid Hemorrhage Patients: A Prospective, Multicenter, Single Blind Randomized Controlled Trial.

Subarachnoid hemorrhage (SAH) patients have oxidative stress results in inflammation, tissue degeneration and neuronal damage. These deleterious effects cause aggravation of the perihematomal edema (P... We conducted a prospective, multicenter randomized (single blind) trial between January 2017 and October 2019, investigating whether antioxidants (acetylcysteine and selenium) have the potential to im... In total, 293 patients were enrolled with 103 patients remaining after applying the inclusion and exclusion criteria. No significant differences were observed in the baseline characteristics between t... In conclusion, antioxidant treatment failed to show the reduction of PHE volume, mid-line shifting, vasospasm and hydrocephalus in acute SAH patients. A significant reduction in ICU stay was observed ... Clinical Research Information Service Identifier: KCT0004628....

Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial.

Antipsychotics are essential in the acute treatment of and maintenance therapy for schizophrenia, but medication adherence and long-term treatment continuity are needed to maximize their effectiveness... In this single-blind, placebo-controlled, crossover trial, we plan to recruit 20 adult patients with schizophrenia spectrum disorder who take sublingual asenapine tablets. The participants will be div... This study aims to determine the efficacy of D-sorbitol in masking the bitter taste of asenapine. To our knowledge, it is the first intervention study using D-sorbitol for bitter taste of asenapine in... This study was registered in the Japan Registry of Clinical Trials jRCTs041210019, on May 14, 2021. Ethics approval was obtained from the Nagoya University Clinical Research Review Board....

Immediate Effects of Mulligan Mobilization on Elbow Proprioception in Healthy Individuals: A Randomized Placebo-Controlled Single-Blind Study.

The aim of this study was to investigate the immediate effects of Mulligan's mobilization with movement (MWM) on elbow proprioception.... The study included 26 participants in the intervention group and 30 participants in the control group. The intervention group received MWM, while the control group received a sham application. Proprio... At 110° of elbow flexion, group × time interaction was significant (F[2, 108] = 11.48, P = .001). In the paired comparisons, there was a statistically significant difference in favor of the control gr... In this study of healthy participants, no immediate difference was found between MWM and sham application on elbow proprioception....

Study Protocol of a Multicenter, Randomized, Single-Blind Trial: Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU Patients.

Pharmacodynamic and pharmacokinetic studies in animal experiments and a phase 1 study suggested remimazolam tosylate as an effective and safe sedation/anesthetic agent. However, the effects and safety... Sixty ICU patients requiring sedation treatment and undergoing mechanical ventilation will be enrolled and randomly assigned to a high dose group (HD group, 30 cases) and a low dose group (LD group, 3... ClinicalTrials.gov identifier, NCT05152303....

Efficacy and Safety of Remimazolam Besylate Combined with Alfentanil in Painless Gastroscopy: A Randomized, Single-Blind, Parallel Controlled Study.

The efficacy and adverse reactions of remimazolam besylate (RB) in combination with alfentanil in patients with painless gastroscopy remain unclear.... The aim of the study is to observe the efficacy and adverse reactions of RB in combination with alfentanil in patients with painless gastroscopy RB.... All patients were randomly divided into two groups: RB combined with the alfentanil group (research group) and propofol combined with the alfentanil group (control group). After full oxygen inhalation... The HR and BP of the patients in the research group and the control group decreased, with a greater decrease in the control group, and the difference was statistically significant (... RB combined with alfentanil can provide safe and effective sedation for patients undergoing painless gastroscopy. Compared with propofol, RB and alfentanil for injection can avoid large hemodynamic fl...

Effectiveness of risk-based caries management among Chinese preschool children: a randomized controlled single-blind trial.

Early childhood caries (ECC) remain a serious oral health problem on a global scale. Risk-based caries management (RBCM) implemented in some parts of the world has been effective in preventing ECC. Ho... Three- to five-year-old children from four kindergartens in Wanzhou were randomly selected for baseline dental examination and caries risk assessment (CRA) and randomly assigned to the experimental gr... Complete data were collected from 291 children (EG, N = 140, 84.8%; CG, N = 181, 83.4%). A total of 25.7% of the EG and 50.3% of the CG children developed new caries, with newly added dmft scores of 0... RBCM effectively prevented new caries in 3- to 5-year-old Wanzhou children and reduced the proportion of children at increased risk of caries. It is an effective approach for preventing ECC.... This trial was registered in the Chinese Clinical Trials Register. The registration number was ChiCTR230067551 (11/01/2023)....

Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.

The objective of this study is to compare the effectiveness of lower limb low-load blood flow restriction training (LL-BFRT) with high-load strength training (HL-ST) as part of an outpatient pulmonary... Participants were randomised to LL-BFRT or HL-ST (24 sessions). LL-BFRT was done at 30% 1-repetition maximum (1-RM) with 70% arterial occlusion pressure. HL-ST was done at 70% 1-RM. Primary outcome wa... We included 30 participants (13 women, 17 men, 64 (9) years, forced expiratory volume in 1 s 47 (18)% pred.), 24 completed the study. Isometric knee extensor strength improved to a clinically relevant... In patients with stable COPD undergoing outpatient pulmonary rehabilitation, LL-BFRT was not superior to HL-ST in improving leg strength. LL-BFRT led to similar strength gains as HL-ST while reducing ... NCT04151771....

Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study.

Exposure to PM... Levels of PM... The result revealed that the interpretation contribution rate of drug use was more than that of PM... The study shows positive effects of air purifier on SCAD, and also provides methodological reference for future related research....